Reaction
Respiratory Tract Irritation reporting signals
As of the last recalculation, Respiratory Tract Irritation appears in 1,028 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is TOBRAMYCIN (PRR 41.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tobramycin | 47 | 41.4 | 41.5 |
| Tobramycin Sulfate | 24 | 40.2 | 40.2 |
| Tobramycin Solution | 23 | 39.6 | 39.7 |
| Salmeterol Xinafoate | 16 | 38.2 | 38.2 |
| Amikacin | 31 | 37.9 | 38.0 |
| Levodopa | 18 | 30.7 | 30.7 |
| Dornase Alfa | 21 | 22.1 | 22.1 |
| 0Xygen | 46 | 19.7 | 19.8 |
| Oxygen | 46 | 19.7 | 19.8 |
| Treprostinil | 107 | 19.2 | 19.2 |
| Umeclidinium | 8 | 18.2 | 18.2 |
| Fluticasone Propionate And Salmeterol | 36 | 18.1 | 18.1 |
| Fluticasone Propionate And Salmeterol Xinafoate | 51 | 18.0 | 18.1 |
| Fluticasone Furoate And Vilanterol Trifenatate | 30 | 17.4 | 17.4 |
| Fluticasone Furoate | 9 | 15.2 | 15.2 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 9 | 14.7 | 14.7 |
| Tiotropium Bromide Inhalation Spray | 8 | 14.6 | 14.6 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 11 | 13.5 | 13.5 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 24 | 12.0 | 12.0 |
| Ivacaftor | 4 | 10.2 | 10.2 |
| Inclisiran | 4 | 10.1 | 10.1 |
| Lumacaftor And Ivacaftor | 4 | 9.5 | 9.5 |
| Nintedanib | 13 | 8.5 | 8.5 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 6 | 7.8 | 7.8 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 3 | 6.8 | 6.8 |
| Benralizumab | 6 | 6.1 | 6.1 |
| Ambrisentan | 34 | 5.7 | 5.7 |